.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDis.A02BA04_Nizatidine.Nizatidine .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDis.A02BA04_Nizatidine.Nizatidine| name: | Nizatidine |
| ATC code: | A02BA04 | route: | oral |
| n-compartments | 1 |
Nizatidine is a histamine H2-receptor antagonist used to reduce stomach acid production, commonly prescribed for the treatment of peptic ulcers and gastroesophageal reflux disease (GERD). It is an approved drug and still clinically used.
Pharmacokinetic parameters reported in healthy adult subjects after a single oral dose.
Avner, DL (2000). Clinical experience with pantoprazole in gastroesophageal reflux disease. Clinical therapeutics 22(10) 1169–1150. DOI:10.1016/s0149-2918(00)83061-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11110229